Alba Therapeutics Study
7/08

The Celiac Sprue Association, as a service to the membership and celiac community, provides the following opportunity to participate in Alba therapeutics clinical trials with larazotide acetate (AT-1001). Of special interest to Alba are people who have been diagnosed within the past year. This is the first drug therapy to reach this stage of clinical trials. Participants from all parts of the United States are needed.

"Alba Therapeutics is sponsoring a clinical trial on Celiac Disease. If you are aged 18-72, have biopsy-proven celiac disease and have been on a gluten-free diet for at least 6 months, you may qualify.

For more information, send an e-mail to clintrials@albatherapeutics.com or call 1-877-415-3282."

There is information about the clinical trials on the Clinical Trials.gov website: http://www.clinicaltrials.gov/ct2/results?term=%22alba+therapeutics%22

The last paragraph on the Celiac Disease page of the ALBA Therapeutics website describes a little of what their study is targeting: http://www.albatherapeutics.com/ProductDevelopment/TherapeuticAreas/CeliacDisease/tabid/80/Default.aspx